Jennifer L. Taubert - 13 Feb 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WWC. Innovative Medicine
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Jennifer Taubert
Issuer symbol
JNJ
Transactions as of
13 Feb 2025
Transactions value $
-$1,616,288
Form type
4
Filing time
18 Feb 2025, 21:08:02 UTC
Previous filing
12 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1.3K +0.78% $0.00 167K 13 Feb 2025 Direct F1
transaction JNJ Common Stock Tax liability -$63.7K -410 -0.25% $155.26 167K 14 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +4.05K +2.43% $0.00 171K 14 Feb 2025 Direct F3
transaction JNJ Common Stock Tax liability -$211K -1.35K -0.79% $156.71 170K 14 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +1.59K +0.94% $0.00 171K 15 Feb 2025 Direct F4
transaction JNJ Common Stock Tax liability -$102K -651 -0.38% $156.15 170K 18 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +15.5K +9.07% $0.00 186K 14 Feb 2025 Direct F5
transaction JNJ Common Stock Tax liability -$1.24M -7.91K -4.25% $156.71 178K 14 Feb 2025 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1.3K -50% $0.00 1.3K 13 Feb 2025 Common Stock 1.3K Direct F1, F7
transaction JNJ Restricted Share Units Options Exercise $0 -4.05K -100% $0.00 0 14 Feb 2025 Common Stock 4.05K Direct F3
transaction JNJ Restricted Share Units Options Exercise $0 -1.59K -33.33% $0.00 3.19K 15 Feb 2025 Common Stock 1.59K Direct F4, F7
transaction JNJ Performance Share Units Options Exercise $0 -15.5K -100% $0.00 0 14 Feb 2025 Common Stock 15.5K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of RSUs.
F3 Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting.
F4 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
F5 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.
F6 Shares withheld for payment of taxes upon vesting of PSUs.
F7 Each RSU represents a contingent right to receive one share of Company Common Stock.